The effectiveness and value of AMX0035 and oral edaravone for amyotrophic lateral sclerosis: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council

Detalles Bibliográficos
Autores principales: Nikitin, Dmitriy, Makam, Anil N, Suh, Kangho, McKenna, Avery, Carlson, Josh J, Richardson, Marina, Rind, David M, Pearson, Steven D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2023
Materias:
Perspectives on Value
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387989/
https://www.ncbi.nlm.nih.gov/pubmed/36705279
http://dx.doi.org/10.18553/jmcp.2023.29.2.216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387989/
https://www.ncbi.nlm.nih.gov/pubmed/36705279
http://dx.doi.org/10.18553/jmcp.2023.29.2.216

Ejemplares similares